• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水性配体进入和离开 G 蛋白偶联受体结合位点-SMD 和 SuMD 模拟。

The Hydrophobic Ligands Entry and Exit from the GPCR Binding Site-SMD and SuMD Simulations.

机构信息

Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland.

Department of Chemistry, Faculty of Sciences, Sorbonne Université, 75005 Paris, France.

出版信息

Molecules. 2020 Apr 21;25(8):1930. doi: 10.3390/molecules25081930.

DOI:10.3390/molecules25081930
PMID:32326322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7221835/
Abstract

Most G protein-coupled receptors that bind the hydrophobic ligands (lipid receptors and steroid receptors) belong to the most populated class A (rhodopsin-like) of these receptors. Typical examples of lipid receptors are: rhodopsin, cannabinoid (CB), sphingosine-1-phosphate (S1P) and lysophosphatidic (LPA) receptors. The hydrophobic ligands access the receptor binding site from the lipid bilayer not only because of their low solubility in water but also because of a large N-terminal domain plug preventing access to the orthosteric binding site from the extracellular milieu. In order to identify the most probable ligand exit pathway from lipid receptors CB1, S1P1 and LPA1 orthosteric binding sites we performed at least three repeats of steered molecular dynamics simulations in which ligands were pulled in various directions. For specific ligands being agonists, the supervised molecular dynamics approach was used to simulate the ligand entry events to the inactive receptor structures. For all investigated receptors the ligand entry/exit pathway goes through the gate between transmembrane helices TM1 and TM7, however, in some cases it combined with a direction toward water milieu.

摘要

大多数与疏水性配体(脂类受体和甾体类受体)结合的 G 蛋白偶联受体都属于这些受体中分布最广的 A 类(视紫红质样)。脂类受体的典型例子有:视紫红质、大麻素(CB)、鞘氨醇-1-磷酸(S1P)和溶血磷脂酸(LPA)受体。疏水性配体不仅由于其在水中的低溶解度,而且由于大的 N 端结构域堵塞,阻止了配体从细胞外环境进入正位结合位点,从而进入受体结合位点。为了确定从 CB1、S1P1 和 LPA1 正位结合位点的脂类受体中最可能的配体出口途径,我们至少进行了三次导向分子动力学模拟,其中将配体沿不同方向拉动。对于特定的配体作为激动剂,使用有监督的分子动力学方法模拟配体进入非活性受体结构的事件。对于所有研究的受体,配体的进入/退出途径都通过跨膜螺旋 TM1 和 TM7 之间的门,但在某些情况下,它与朝向水介质的方向相结合。

相似文献

1
The Hydrophobic Ligands Entry and Exit from the GPCR Binding Site-SMD and SuMD Simulations.疏水性配体进入和离开 G 蛋白偶联受体结合位点-SMD 和 SuMD 模拟。
Molecules. 2020 Apr 21;25(8):1930. doi: 10.3390/molecules25081930.
2
Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.CB1 cannabinoid receptor 的疏水配体进入和退出途径。
J Chem Inf Model. 2016 Dec 27;56(12):2457-2466. doi: 10.1021/acs.jcim.6b00499. Epub 2016 Dec 14.
3
Endogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulations.内源性脂质激活的 G 蛋白偶联受体:晶体学和分子动力学模拟揭示的新结构特征。
Chem Phys Lipids. 2013 Apr;169:46-56. doi: 10.1016/j.chemphyslip.2013.01.009. Epub 2013 Feb 26.
4
Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.疏水性和氢键相互作用对 G 蛋白偶联胰高血糖素受体抑制剂 β-丙氨酸类似物活性的影响。
Proteins. 2020 Feb;88(2):327-344. doi: 10.1002/prot.25807. Epub 2019 Sep 10.
5
Ligand chain length drives activation of lipid G protein-coupled receptors.配体链长驱动脂类 G 蛋白偶联受体的激活。
Sci Rep. 2017 May 17;7(1):2020. doi: 10.1038/s41598-017-02104-5.
6
Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.计算研究配体与大麻素激活的 G 蛋白偶联受体 GPR18 的结合模式。
Biomolecules. 2020 Apr 29;10(5):686. doi: 10.3390/biom10050686.
7
Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.将A类G蛋白偶联受体与苦味受体进行比较:结构基序、配体相互作用及激动剂与拮抗剂比例
Methods Cell Biol. 2016;132:401-27. doi: 10.1016/bs.mcb.2015.10.005. Epub 2015 Dec 24.
8
Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.G蛋白偶联受体激动剂与拮抗剂的分化及相互转化方法
Methods Mol Biol. 2018;1705:265-296. doi: 10.1007/978-1-4939-7465-8_12.
9
Evidence for a Transient Additional Ligand Binding Site in the TAS2R46 Bitter Taste Receptor.味觉2型受体46(TAS2R46)苦味受体中存在短暂额外配体结合位点的证据。
J Chem Theory Comput. 2015 Sep 8;11(9):4439-49. doi: 10.1021/acs.jctc.5b00472. Epub 2015 Aug 24.
10
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?脂质双层是否调控配体与 G 蛋白偶联受体跨膜正构/变构位点的结合和进入?
Mol Pharmacol. 2019 Nov;96(5):527-541. doi: 10.1124/mol.118.115113. Epub 2019 Apr 8.

引用本文的文献

1
Residence time in drug discovery: current insights and future perspectives.药物研发中的驻留时间:当前见解与未来展望。
Pharmacol Rep. 2025 Jun 9. doi: 10.1007/s43440-025-00748-z.
2
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.针对大麻素受体CB1的FDA批准化合物的计算和实验性药物重新利用
Pharmaceuticals (Basel). 2023 Dec 2;16(12):1678. doi: 10.3390/ph16121678.
3
Ligand entry pathways control the chemical space recognized by GPR183.配体进入途径控制GPR183识别的化学空间。

本文引用的文献

1
Molecular switches in GPCRs.G 蛋白偶联受体中的分子开关。
Curr Opin Struct Biol. 2019 Apr;55:114-120. doi: 10.1016/j.sbi.2019.03.017. Epub 2019 May 10.
2
Emerging structural biology of lipid G protein-coupled receptors.脂质 G 蛋白偶联受体的新兴结构生物学。
Protein Sci. 2019 Feb;28(2):292-304. doi: 10.1002/pro.3509.
3
GPCRdb in 2018: adding GPCR structure models and ligands.GPCRdb 在 2018 年:增加 GPCR 结构模型和配体。
Chem Sci. 2023 Sep 25;14(39):10671-10683. doi: 10.1039/d2sc05962b. eCollection 2023 Oct 11.
4
Enrichment and fragmentation approaches for enhanced detection and characterization of endogenous glycosylated neuropeptides.富集和碎片化方法可增强内源性糖基化神经肽的检测和表征。
Proteomics. 2023 Feb;23(3-4):e2100375. doi: 10.1002/pmic.202100375. Epub 2022 Aug 15.
5
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.共价大麻素受体配体——结构洞察与选择性挑战。
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
6
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.A类脂质G蛋白偶联受体的结构、功能与药理学研究进展:药物研发的机遇与挑战
Pharmaceuticals (Basel). 2021 Dec 22;15(1):12. doi: 10.3390/ph15010012.
7
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.大麻素 CB1 受体的变构调节:大麻二酚 - 对 N 端结构域和变构-变构偶联的分子建模研究。
Molecules. 2021 Apr 23;26(9):2456. doi: 10.3390/molecules26092456.
Nucleic Acids Res. 2018 Jan 4;46(D1):D440-D446. doi: 10.1093/nar/gkx1109.
4
Crystal structures of agonist-bound human cannabinoid receptor CB.激动剂结合的人源大麻素受体CB的晶体结构
Nature. 2017 Jul 27;547(7664):468-471. doi: 10.1038/nature23272. Epub 2017 Jul 5.
5
Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.CB1 cannabinoid receptor 的疏水配体进入和退出途径。
J Chem Inf Model. 2016 Dec 27;56(12):2457-2466. doi: 10.1021/acs.jcim.6b00499. Epub 2016 Dec 14.
6
High-resolution crystal structure of the human CB1 cannabinoid receptor.人类CB1大麻素受体的高分辨率晶体结构。
Nature. 2016 Dec 22;540(7634):602-606. doi: 10.1038/nature20613. Epub 2016 Nov 16.
7
Crystal Structure of the Human Cannabinoid Receptor CB.人类大麻素受体CB的晶体结构
Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.
8
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.使用CHARMM36加和力场的NAMD、GROMACS、AMBER、OpenMM和CHARMM/OpenMM模拟的CHARMM-GUI输入生成器。
J Chem Theory Comput. 2016 Jan 12;12(1):405-13. doi: 10.1021/acs.jctc.5b00935. Epub 2015 Dec 3.
9
Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1.拮抗剂结合的人溶血磷脂酸受体1的晶体结构
Cell. 2015 Jun 18;161(7):1633-43. doi: 10.1016/j.cell.2015.06.002.
10
New ways to boost molecular dynamics simulations.增强分子动力学模拟的新方法。
J Comput Chem. 2015 May 15;36(13):996-1007. doi: 10.1002/jcc.23899. Epub 2015 Mar 30.